Skip to content

Bigfoot Unity Diabetes Management System FG-300186Recalls & reported problems

Bigfoot Biomedical, Inc. · Bigfoot Unity Diabetes Management System for Humalog-Lispro-Lyumjev and Toujeo Only · Class 2

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00850003506234), received between Aug 1, 2023 and Aug 1, 2023 — classified as 2 injuries.

1 other recall cover devices cleared under the same FDA submission (K202145); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem2

Patient problems

  • Hyperglycemia1
  • Hypoglycemia1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • InjuryAug 1, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    PATIENT REPORTED THAT THEY HAD EXPERIENCED A SEVERE HYPOGLYCEMIC EVENT DURING THE PREVIOUS TWO WEEKS. NO FURTHER INFORMATION WAS PROVIDED. MULTIPLE ATTEMPTS TO COLLECT ADDITIONAL INFORMATION WERE UNSUCCESSFUL.

    Patient problems: Hypoglycemia

    MAUDE report 17438516 ↗
  • InjuryAug 1, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    PATIENT REPORTED THAT THEY WERE HOSPITALIZED WITH BG LEVELS OF 1500 MG/DL. PATIENT REPORTED THAT THEIR LONG-ACTING INSULIN WAS CHANGED RECENTLY FROM NOVOLIN-N (USING VIAL/SYRINGE) TO TOUJEO (USING INSULIN PEN), AND THEY JUST STARTED USING BIGFOOT UNITY SYSTEM.

    Patient problems: Hyperglycemia

    MAUDE report 17436431 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under K202145. One submission often covers many models, so check the product and lot details in each record.

  • Z-1997-2025 · May 21, 2025 · Open, Classified
    Bigfoot Unity Diabetes Management System SW-300689-01 Bigfoot Inject v1 Pen Cap LCAP Firmware 1.3.0 Release Configuration, Rev H SW-300689-02 Bigfoot Inject v1 Pen Cap RCAP Firmwar

Other Integrated Continuous Glucose Monitoring System, Factory Calibrated, Not For Use With Automated Insulin Delivery Systems devices

All Integrated Continuous Glucose Monitoring System, Factory Calibrated, Not For Use With Automated Insulin Delivery Systems devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page